Codexis (CDXS) Cash from Financing Activities (2010 - 2026)
Codexis (CDXS) posted quarterly Cash from Financing Activities of -$14000.0 for Q1 2026, down 101.29% year-over-year from $1.1 million in Q1 2025, and down 107.78% quarter-over-quarter from $180000.0 in Q4 2025.
Codexis (CDXS) Cash from Financing Activities (2010 - 2026) Analysis & Trends
Codexis' Cash from Financing Activities history runs 17 years deep, the most recent figure standing at -$14000.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities fell 101.29% year-over-year to -$14000.0; the TTM figure through Mar 2026 stood at $26.8 million (down 17.0% YoY), while the FY2025 annual figure was $27.9 million, down 53.85% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$14000.0, down from $180000.0 in the prior quarter.
- The five-year high for Cash from Financing Activities was $30.3 million in Q3 2024, with the low at -$1.3 million in Q1 2022.
- The 5-year median for Cash from Financing Activities is $286000.0 (2022), against an average of $6.0 million.
- The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities tumbled 7629.41% in 2022, then soared 28161.11% in 2024.
- Codexis' Cash from Financing Activities stood at $339000.0 in 2022, then tumbled by 131.86% to -$108000.0 in 2023, then jumped by 1148.15% to $1.1 million in 2024, then plunged by 84.1% to $180000.0 in 2025, then plunged by 107.78% to -$14000.0 in 2026.
- Business Quant data shows CDXS's Cash from Financing Activities at -$14000.0 in Q1 2026, $180000.0 in Q4 2025, and -$111000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -426.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -1.22 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 14.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -6.05 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 36.24 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -16.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 27.18 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -273.15 Mn |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn | 66,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 66,000.00 |
| Jun 30, 2026 | 66,000.00 |
| Mar 31, 2026 | -14,000.00 |
| Mar 31, 2026 | -14,000.00 |
| Dec 31, 2025 | 180,000.00 |
| Dec 31, 2025 | 180,000.00 |
| Sep 30, 2025 | -111,000.00 |
| Sep 30, 2025 | -111,000.00 |
| Jun 30, 2025 | 26.77 Mn |
| Jun 30, 2025 | 26.77 Mn |
| Mar 31, 2025 | 1.09 Mn |
| Mar 31, 2025 | 1.09 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 30.31 Mn |
| Sep 30, 2024 | 30.31 Mn |
| Jun 30, 2024 | -197,000.00 |
| Jun 30, 2024 | -197,000.00 |
| Mar 31, 2024 | 29.28 Mn |
| Mar 31, 2024 | 29.28 Mn |